ESNT Earnings

ESNT reported its earnings on 2026-02-13, showcasing a revenue of 312.40M against an estimate of 311.01M, resulting in a 0.45% surprise. The EPS was 1.6, surpassing the expected 1.74 by -8.05%. The stock experienced a -6.43% price change on the earnings day and a -8.26% change over the next five days, reflecting market reactions to the results.

Following ESNT's earnings announcement on 2026-02-13, the stock price moved by -6.43% on the day of the release. Over the subsequent five days, it saw a -8.26% change. Historically, ESNT's stock price tends to shift by an average of 1.91% in the 10 days leading up to earnings and 1.82% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ESNT's annual revenue to reach 316.61M, while the EPS is projected at 1.75. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised downward by -1.34% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ESNT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved revised downward by -1.34%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ESNT's stock price typically moves by 1.91% in the 10 days before its earnings and 1.82% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 1.75 and revenue of 316.61M.

The earnings call highlights strong financial performance with a 13% increase in book value per share and significant shareholder returns, including a 10% reduction in shares outstanding. Despite some concerns raised in the Q&A, such as lower NIW and stable gross premium yield, the company's strategic focus on long-term value and capital efficiency, including entering the Lloyd's market, supports a positive outlook. The optimistic guidance and robust financial health are likely to result in a positive stock price movement over the next two weeks.